Massachussetts General Hospital — Boston, Massachusetts

Massachussetts General Hospital is a clinical research site located in Boston, Massachusetts, United States 02114.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

Massachussetts General Hospital has participated in 11 clinical trials with 1 currently active.

Therapeutic areas: Hepatocellular Cancer, Liver Cancer, Carcinoma, Non-Small-Cell Lung.

Sponsors: OncoMed Pharmaceuticals, Inc., Pfizer, Massachusetts General Hospital.

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Massachussetts General Hospital?

Massachussetts General Hospital has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Massachussetts General Hospital conducted?

Massachussetts General Hospital has 11 clinical trials on record, with 1 currently active. Their work covers Hepatocellular Cancer, Liver Cancer, Carcinoma, Non-Small-Cell Lung.

Is Massachussetts General Hospital accredited by Crixeo Health?

Yes — Massachussetts General Hospital holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Massachussetts General Hospital?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.